UBS O'Connor’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,779
| Closed | -$107K | – | 335 |
|
|
2024
Q4 | $107K | Hold |
51,779
| – | – | ﹤0.01% | 315 |
|
|
2024
Q3 | $91.1K | Buy |
51,779
+4,809
| +10% | +$8.46K | ﹤0.01% | 376 |
|
|
2024
Q2 | $679K | Buy |
46,970
+1,294
| +3% | +$18.7K | 0.02% | 340 |
|
|
2024
Q1 | $760K | Sell |
45,676
-15,383
| -25% | -$256K | 0.02% | 298 |
|
|
2023
Q4 | $980K | Sell |
61,059
-53,419
| -47% | -$857K | 0.03% | 268 |
|
|
2023
Q3 | $1.54M | Buy |
114,478
+34,000
| +42% | +$457K | 0.03% | 276 |
|
|
2023
Q2 | $1.38M | Sell |
80,478
-789
| -1% | -$13.6K | 0.03% | 343 |
|
|
2023
Q1 | $1.34M | Buy |
+81,267
| New | +$1.34M | 0.03% | 375 |
|
|
2022
Q4 | – | Sell |
-60,943
| Closed | -$1.04M | – | 143 |
|
|
2022
Q3 | $1.04M | Sell |
60,943
-30,000
| -33% | -$513K | 0.01% | 731 |
|
|
2022
Q2 | $994K | Buy |
+90,943
| New | +$994K | 0.01% | 756 |
|